RxDoctor Payments Data

Siu Fung Chan, MD

Pain Medicine · Cincinnati, OHNPI 1750523551

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.8% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Boston Scientific at 36.5% of the total. Reporting peaked in 2019 at $2,274 and has fallen 63.1% since, to $838 in 2025.

$8,551in general payments, 2019–2025

Across 126 payments — averaging $67.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$3K
  • Amgen$651
  • Abbott$562
  • Vertos Medical, Inc.$470
  • Averitas Pharma Inc.$223
  • plus $837 from 10 others

What the payments were for

  • Travel & lodging$6187%
  • Food & beverage$7,93293%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,551 in reported general payments places this provider in the 75th percentile of 245 pain medicine providers in Ohio.

See all pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$84,017
Medicare patients
265
Services billed
941

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen909$24,135
NucyntaTapentadol Hcl12$16,917
Lidocaine134$15,310
Xtampza ErOxycodone Myristate28$14,014
Pregabalin396$11,365
Gabapentin722$9,874
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen411$9,016
Oxycodone Hcl430$7,339
Celecoxib155$6,634
Fentanyl40$5,842
Metaxalone17$4,457
Methadone Hcl310$4,196
Tizanidine Hcl421$3,930
Morphine Sulfate ErMorphine Sulfate155$3,779
Diclofenac Sodium90$3,648

Paid to pharmacies, not to this prescriber.

Other pain medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →